This year’s Metsquerade will be virtual due to COVID-19 and in an abundance of caution to two of the Metsquerade organizers. Please continue to purchase tickets to the virtual event and donate as we hope to surpass $1.5 million since starting the NWA Metsquerade in 2016.
Thank you, the NWA Metsquerade Team

5th Annual NWA Metsquerade: October 24, 2020


The NWA Metsquerade is a fundraiser for Metavivor, a non-profit organization that uses 100% of donations for metastatic breast cancer research.

Read More About Metavivor


We will continue to raise funds to support metastatic breast cancer research. Any contribution is greatly appreciated.

Donate Today!


Total raised since 2016...

The NWA Metsquerade has raised over $1.2 million since 2016 including monies raised from the annual NWA NWA Metsquerade, Annual Runway IV Reseach, National Metaribbon Challenge, and various other fundraisers.  The team has helped fund the following grants:
The METAribbon Challengers present Julio Aguirre-Ghiso, PhD, Professor, Medicine, Hematology and Medical Oncology, Otolaryngology, Oncological Sciences, Icahn School of Medicine “Targeting Intrinsic And Immune Mechanisms In Persistent Dormant Cancer Cells In Stage IV Breast Cancer” 2018
The Davis-Quinn Northwest Arkansas Metsquerade presents Brad St Croix, PhD, Senior Associate Scientist, National Cancer Institute “Improving Immunotherapies for Advanced Metastatic Breast Cancer” 2018
The Quinn-Davis Northwest Arkansas Metsquerade presents Dr. Cheryl Jorcyk, Director of Clinical/Translational Research, Boise State University: “High impact therapeutic for the elimination of breast cancer metastasis to bone” 2017
The Parker-Quinn NWA Metsquerade award for donating over $100,000 to research. 2016

Honorary Chair Dr. Tim Pluard

Timothy J. Pluard, MD, is a breast medical oncologist with an exclusive focus on metastatic breast cancer and serves as medical director of Saint Luke’s Cancer Institute in Kansas City, Missouri. Under his leadership, Saint Luke’s launched its innovative Koontz Center for Advanced Breast Cancer in 2016, the first center devoted exclusively to improving the outcomes and quality of life for patients with metastatic breast cancer. He is a nationally recognized thought leader on new therapeutics and the multidisciplinary care of patients with MBC.

Prior to joining Saint Luke’s, Dr. Pluard served as associate professor of medicine at Washington University in Saint Louis, and clinical director of breast oncology at Siteman Center, a National Cancer Institute designated Comprehensive Cancer Center.

He is a graduate of the Washington University School of Medicine and completed his oncology fellowship training at Dana-Farber Cancer Institute at Harvard Medical School.

Faces of Metastatic Breast Cancer


Thirty percent of women and men who are diagnosed with breast cancer will eventually develop stage 4 (metastatic) breast cancer and die. Yet of all the money dedicated to breast cancer research, only 2-5% is earmarked specifically for metastatic research. METAvivor’s goal is to have cancer organizations devote 30% of their research budget to research that will help the 30% of women and men whose cancer metastasizes.

The surest way to save the lives of patients already diagnosed with breast cancer is to find a way to make MBC survivable.




Name *
Email *

(479) 790-4826

PO Box 8094, 72766
Springdale, AR